SE0301947D0 - New method and uses - Google Patents

New method and uses

Info

Publication number
SE0301947D0
SE0301947D0 SE0301947A SE0301947A SE0301947D0 SE 0301947 D0 SE0301947 D0 SE 0301947D0 SE 0301947 A SE0301947 A SE 0301947A SE 0301947 A SE0301947 A SE 0301947A SE 0301947 D0 SE0301947 D0 SE 0301947D0
Authority
SE
Sweden
Prior art keywords
akg
vertebrate
bird
adsorption
including mammal
Prior art date
Application number
SE0301947A
Other languages
English (en)
Swedish (sv)
Inventor
Stefan G Pierzynowski
Douglas Burrin
Original Assignee
Gramineer Internat Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gramineer Internat Ab filed Critical Gramineer Internat Ab
Priority to SE0301947A priority Critical patent/SE0301947D0/xx
Publication of SE0301947D0 publication Critical patent/SE0301947D0/xx
Priority to US10/562,953 priority patent/US20060247207A1/en
Priority to CNA2008100926372A priority patent/CN101301285A/zh
Priority to RU2005140739/15A priority patent/RU2360671C2/ru
Priority to AU2004254154A priority patent/AU2004254154B2/en
Priority to EP04749100A priority patent/EP1638546A1/en
Priority to BRPI0412118-0A priority patent/BRPI0412118A/pt
Priority to KR1020057025525A priority patent/KR101196036B1/ko
Priority to JP2006517059A priority patent/JP4847323B2/ja
Priority to MXPA05013901A priority patent/MXPA05013901A/es
Priority to CA002530863A priority patent/CA2530863A1/en
Priority to CN2004800203227A priority patent/CN1822827B/zh
Priority to PCT/SE2004/001062 priority patent/WO2005002567A1/en
Priority to HK06113762.3A priority patent/HK1093016A1/xx
Priority to US12/626,549 priority patent/US20100069498A1/en
Priority to JP2011165159A priority patent/JP2011225609A/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SE0301947A 2003-07-01 2003-07-01 New method and uses SE0301947D0 (sv)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SE0301947A SE0301947D0 (sv) 2003-07-01 2003-07-01 New method and uses
PCT/SE2004/001062 WO2005002567A1 (en) 2003-07-01 2004-07-01 Use of alpha-ketoglutaric acid for the treatment of malnutrition or high plasma glucose condition
BRPI0412118-0A BRPI0412118A (pt) 2003-07-01 2004-07-01 métodos para melhorar a absorção de aminoácidos, para reduzir a absorção da glicose plasmática, e para prevenir, inibir ou aliviar uma condição de elevado teor de glicose em um vertebrado, e, uso de akg, derivados ou metabólitos de akg, análogos de akg, ou misturas destes
JP2006517059A JP4847323B2 (ja) 2003-07-01 2004-07-01 栄養失調及び高血漿グルコース状態を治療するためのアルファ−ケトグルタル酸の使用
RU2005140739/15A RU2360671C2 (ru) 2003-07-01 2004-07-01 Применение альфа-кетоглутаровой кислоты для лечения недостаточности питания или состояния с высоким уровнем глюкозы в плазме
AU2004254154A AU2004254154B2 (en) 2003-07-01 2004-07-01 Use of alpha-ketoglutaric acid for the treatment of malnutrition or high plasma glucose condition
EP04749100A EP1638546A1 (en) 2003-07-01 2004-07-01 Use of alpha-ketoglutaric acid for the treatment of malnutrition or high plasma glucose condition
US10/562,953 US20060247207A1 (en) 2003-07-01 2004-07-01 Use of alpha-ketoglutaric acid for the treatment of malnutrition or high plasma glucose condition
KR1020057025525A KR101196036B1 (ko) 2003-07-01 2004-07-01 영양실조 또는 높은 혈장 글루코스 상태를 치료하기 위한알파-케토글루타르산의 용도
CNA2008100926372A CN101301285A (zh) 2003-07-01 2004-07-01 α-酮戊二酸用于治疗营养不良或高血浆葡萄糖症状的用途
MXPA05013901A MXPA05013901A (es) 2003-07-01 2004-07-01 Uso de acido alfa-cetoglutarico para tratamiento de desnutricion o condicion de glucosa alta en plasma.
CA002530863A CA2530863A1 (en) 2003-07-01 2004-07-01 Use of alpha-ketoglutaric acid for the treatment of malnutrition or high plasma glucose condition
CN2004800203227A CN1822827B (zh) 2003-07-01 2004-07-01 α-酮戊二酸用于治疗营养不良或高血浆葡萄糖症状的用途
HK06113762.3A HK1093016A1 (en) 2003-07-01 2006-12-14 Use of alpha-ketoglutaric acid for the treatment of malnutrition or high plasma glucose condition
US12/626,549 US20100069498A1 (en) 2003-07-01 2009-11-25 Use of alpha-ketoglutaric acid for the treatment of high plasma glucose condition
JP2011165159A JP2011225609A (ja) 2003-07-01 2011-07-28 栄養失調及び高血漿グルコース状態を治療するためのアルファ−ケトグルタル酸の使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301947A SE0301947D0 (sv) 2003-07-01 2003-07-01 New method and uses

Publications (1)

Publication Number Publication Date
SE0301947D0 true SE0301947D0 (sv) 2003-07-01

Family

ID=27731075

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0301947A SE0301947D0 (sv) 2003-07-01 2003-07-01 New method and uses

Country Status (3)

Country Link
JP (1) JP4847323B2 (ja)
CN (2) CN1822827B (ja)
SE (1) SE0301947D0 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102028102A (zh) * 2010-12-08 2011-04-27 江南大学 一种天然安全的增长型饲料添加剂
CN104304685A (zh) * 2014-11-14 2015-01-28 中国水产科学研究院黑龙江水产研究所 一种提高鲟鱼饲料蛋白质利用率的饲料添加剂及其添加方法
CN105231038A (zh) * 2015-09-23 2016-01-13 华南农业大学 α-酮戊二酸在制备猪饲料添加剂方面的应用
CN105941912A (zh) * 2016-05-16 2016-09-21 华南农业大学 α-酮戊二酸及其盐在制备改善猪胴体组成的饲料添加剂方面的应用
CN107616505B (zh) * 2017-10-24 2020-12-25 精晶药业股份有限公司 一种含有鸟氨酸酮戊二酸的保健品及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE462463B (sv) * 1988-12-02 1990-07-02 Decken Alexandra V D Livs- och fodermedel innehaallande ketosyror
SE9201584D0 (sv) * 1992-05-20 1992-05-20 Vinnars Erik Ab Use of alpha-ketoglutarate
SE9303691D0 (sv) * 1993-11-09 1993-11-09 Gramineer Ab New beverage
JPH10175855A (ja) * 1996-10-16 1998-06-30 Taisho Pharmaceut Co Ltd 肉体疲労改善剤
JP2001521002A (ja) * 1997-10-24 2001-11-06 コーネル リサーチ ファンデーション インク． 脳の代謝機能不全のための栄養補充剤
DE19755367C2 (de) * 1997-12-12 2001-03-22 Afting Ernst Guenter Pharmazeutische Zusammensetzung enthaltend D-Galaktose und ihre Verwendung
NL1014380C2 (nl) * 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
SE0201713D0 (sv) * 2001-11-23 2002-06-06 Gramineer Internat Ab New methods and use III

Also Published As

Publication number Publication date
CN1822827A (zh) 2006-08-23
JP2007529408A (ja) 2007-10-25
JP4847323B2 (ja) 2011-12-28
CN1822827B (zh) 2012-03-28
CN101301285A (zh) 2008-11-12

Similar Documents

Publication Publication Date Title
MY143568A (en) 11b-hsd1 inhibitors for the treatment of diabetes
TW200626558A (en) Indazolone derivatives
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
NO20060416L (no) Ny anvendelse I
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
NO20064347L (no) Substituerte 1,2,3,4-tetrahydroisokinolinderivater
EA200700901A1 (ru) Производные 2-амидо-4-фенилтиазола, их получение и применение в терапии
DK1638586T3 (da) Synergistisk sammensætning til behandling af diabetes mellitus
SE0301886D0 (sv) New use V
UA94052C2 (uk) Похідні піридазину
EA200501268A1 (ru) Ингибирующие вич 1,2,4-триазины
TW200718424A (en) Novel compounds of amino sulfonyl derivatives
IS2517B (is) Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
UY27755A1 (es) Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores.
WO2006048750A3 (en) Novel compounds of substituted and unsubstituted adamantyl amides
BRPI0412851A (pt) benzamidazóis de n-metila-substituìdos
SE0401971D0 (sv) Piperidne derivatives
ATE484508T1 (de) Furylverbindungen
ATE410424T1 (de) Spirocyclische cyclohexan-derivate
ATE373474T1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
EA200800303A1 (ru) Применение производных и аналогов тиазола при нарушениях, вызванных свободными жирными кислотами
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
NO20076425L (no) Fremgangsmater for behandling av drug-resistent cancer
CY1109763T1 (el) Υλικα και μεθοδος για τη θεραπεια διαταραχων πηξης
SE0201713D0 (sv) New methods and use III